Breakthrough Improvement Collaborative for ColoRectal Cancer (BIC4CRC)
BIC4CRC
BIC4CRC: Breakthrough Improvement Collaborative for ColoRectal Cancer
1 other identifier
observational
950
1 country
1
Brief Summary
Colorectal cancer is the most common cancer in Europe and the third worldwide. Approximately 1 in 20 men and 1 in 35 women will develop colorectal cancer at some moment in their life. In Flanders, in 2014, there was an increase in the detection of colorectal cancer with 21% compared to 2013. Early detection improves the prognosis for the patient. In this early stage, colorectal surgery is one of the most important treatments, but it is also complex and has a high complication rate. However, over the last decade, surgical care for patients with colorectal cancer has become more standardized. The use of structured care methods, such as care pathways and protocols, has helped in standardizing care processes. Specifically for patients with colorectal cancer, perioperative care has shifted with the implementation of Enhanced Recovery After Surgery (ERAS) programs. The goal of ERAS- protocols is to optimize the interventions during the perioperative hospitalization period and reduce postoperative complications. Despite the increasing evidence in favor of the use of these standardized protocols, adherence and implementation in daily practice remains challenging. The primary goal of this quality improvement project is to enhance the standardization of key interventions in the ERAS care process for patients undergoing colorectal surgery. Therefore, adherence to the ERAS-guidelines will be investigated and hospitals will receive feedback to set up improvement initiatives. Moreover, interactive group sessions and on-site training activities will stimulate knowledge sharing and define best practices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 13, 2017
CompletedFirst Posted
Study publicly available on registry
October 25, 2017
CompletedStudy Start
First participant enrolled
March 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedFebruary 8, 2023
February 1, 2023
2.5 years
October 13, 2017
February 6, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Length of stay
Number of days in the hospital
through study completion, an average of 4 months
Secondary Outcomes (3)
30-days readmission rate
through study completion, an average of 4 months
Mortality rate
through study completion, an average of 4 months
Complication rate
through study completion, an average of 4 months
Study Arms (1)
Colorectal cancer
Interventions
Learn form international report, Explain key interventions, Explain BIC methodology, Retrospective patient record analysis, Team measures
Feedback report, Share (inter)national best practices, Discussion, set priorities, teaching and improvement, Retrospective patient record analysis
Feedback report, Share best practices, Discussion, set priorities, teaching and improvement, Retrospective patient record analysis, Team measures
Eligibility Criteria
Patient with colorectal cancer admitted for planned surgery
You may qualify if:
- Minimum age of 18 years
- Elective admission for colorectal cancer surgery
You may not qualify if:
- Emergency (not planned) admission for colorectal cancer surgery
- Patients diagnosed with severe dementia or severe concomitant disease that may affect very short term outcome and hence influence deviations from standard acute care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
- Kom Op Tegen Kankercollaborator
Study Sites (1)
KU Leuven
Leuven, Vlaams-brabant, 3000, Belgium
Related Publications (2)
van Zelm R, Janssen I, Vanhaecht K, de Buck van Overstraeten A, Panella M, Sermeus W, Coeckelberghs E. Development of a model care pathway for adults undergoing colorectal cancer surgery: Evidence-based key interventions and indicators. J Eval Clin Pract. 2018 Feb;24(1):232-239. doi: 10.1111/jep.12700. Epub 2017 Feb 1.
PMID: 28145019BACKGROUNDvan Zelm R, Coeckelberghs E, Sermeus W, De Buck van Overstraeten A, Weimann A, Seys D, Panella M, Vanhaecht K. Variation in care for surgical patients with colorectal cancer: protocol adherence in 12 European hospitals. Int J Colorectal Dis. 2017 Oct;32(10):1471-1478. doi: 10.1007/s00384-017-2863-z. Epub 2017 Jul 17.
PMID: 28717841BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 13, 2017
First Posted
October 25, 2017
Study Start
March 30, 2018
Primary Completion
September 30, 2020
Study Completion
December 1, 2025
Last Updated
February 8, 2023
Record last verified: 2023-02